IDYA Crosses Above Average Analyst Target
June 18, 2020 at 08:45 AM EDT
In recent trading, shares of IDEAYA Biosciences Inc (IDYA) have crossed above the average analyst 12-month target price of $15.83, changing hands for $18.57/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..